Searching... please wait. You've got 287 hits!
Acronym | Full Name | Score | Rating | Judge me | Search |
IR | immunoreactive | 205 | 7 | good bad | |
IR | insulin receptor | 134 | 3 | good bad | |
IR | ionizing radiation | 90 | 3 | good bad | |
IR | infrared | 61 | 6 | good bad | |
IR | inverted repeat | 32 | 9 | good bad | |
IR | Immediate Release | 23 | 2 | good bad | |
IR | infrared spectroscopy | 17 | 61 | good bad | |
IR | ischemia-reperfusion | 15 | 8 | good bad | |
IR | inhibition rate | 13 | 234 | good bad | |
IR | immediate-release | 12 | -1 | good bad | |
IR | (NPY)-immunoreactive | 8 | 8 | good bad | |
IR | CGRP-immunoreactive | 6 | 11 | good bad | |
IR | GABA-immunoreactive | 6 | 11 | good bad | |
IR | ischemia and reperfusion | 6 | 3 | good bad | |
IR | incomplete repair | 6 | 1 | good bad | |
IR | HOMA | 5 | 3 | good bad | |
IR | Fos-immunoreactive | 4 | 1194 | good bad | |
IR | (SP)-immunoreactive | 4 | 933 | good bad | |
IR | (5-HT)-immunoreactive | 4 | 75 | good bad | |
IR | Inversion-Recovery | 4 | 11 | good bad | |
IR | inverted repeats | 4 | 10 | good bad | |
IR | information retrieval | 4 | 10 | good bad | |
IR | NPY-immunoreactive | 4 | 8 | good bad | |
IR | ChAT-immunoreactive | 4 | 6 | good bad | |
IR | interventional radiology | 4 | 4 | good bad | |
IR | inferior rectus | 4 | 3 | good bad | |
IR | incidence rates | 3 | 88 | good bad | |
IR | serotonin-immunoreactive | 3 | 67 | good bad | |
IR | ileal reservoir | 3 | 10 | good bad | |
IR | 5-immunoreactive | 3 | 9 | good bad | |
IR | inwardly rectifying K(+) (K | 3 | 5 | good bad | |
IR | intergenic region | 3 | 4 | good bad | |
IR | implantation rate | 3 | 1 | good bad | |
IR | (NOS)-immunoreactive | 3 | 1 | good bad | |
IR | (CRF)-immunoreactive | 2 | 620 | good bad | |
IR | in levels of immunoreactive | 2 | 181 | good bad | |
IR | c-Fos-immunoreactive | 2 | 79 | good bad | |
IR | LHRH-immunoreactive | 2 | 76 | good bad | |
IR | increased the number of Fos-immunoreactive | 2 | 75 | good bad | |
IR | (CRH)-immunoreactive | 2 | 58 | good bad | |
IR | Induction of Fos-like immunoreactivity | 2 | 53 | good bad | |
IR | innervation ratio | 2 | 29 | good bad | |
IR | GFAP-immunoreactivity | 2 | 15 | good bad | |
IR | PNMT-immunoreactive | 2 | 13 | good bad | |
IR | internal rotation | 2 | 12 | good bad | |
IR | intestinal peptide (VIP)-immunoreactive | 2 | 12 | good bad | |
IR | infection rates | 2 | 10 | good bad | |
IR | (AVP)-immunoreactive | 2 | 8 | good bad | |
IR | peptide-immunoreactive | 2 | 8 | good bad | |
IR | Irradiation | 2 | 7 | good bad | |
IR | input resistance | 2 | 6 | good bad | |
IR | inhibitory ratio | 2 | 6 | good bad | |
IR | SUR1/K | 2 | 6 | good bad | |
IR | IGF-I receptors (IGF-IR) and insulin receptors | 2 | 6 | good bad | |
IR | Immediate reconstruction | 2 | 6 | good bad | |
IR | GnRH-immunoreactive | 2 | 3 | good bad | |
IR | intraruminal | 2 | 3 | good bad | |
IR | in immunoreactive | 2 | 2 | good bad | |
IR | inducible resistance | 2 | 1 | good bad | |
IR | Induced Reactivation | 1 | 1468 | good bad | |
IR | GFAP-immunoreactive | 1 | 1447 | good bad | |
IR | in GR immunoreactivity | 1 | 1241 | good bad | |
IR | Intraluminal irradiation | 1 | 1042 | good bad | |
IR | NPY-immunoreactivity | 1 | 1035 | good bad | |
IR | in NIH-3T3 | 1 | 965 | good bad | |
IR | Kit-immunoreactive | 1 | 781 | good bad | |
IR | induce an increase of inward-rectifying | 1 | 757 | good bad | |
IR | gamma-radiation | 1 | 655 | good bad | |
IR | investigated by means of immunocytochemistry | 1 | 593 | good bad | |
IR | inactive renin levels | 1 | 511 | good bad | |
IR | investigated with infrared | 1 | 468 | good bad | |
IR | Spectroscopic | 1 | 462 | good bad | |
IR | identified significant amounts of immunoreactive | 1 | 438 | good bad | |
IR | in Chinese hamster ovary/insulin receptor | 1 | 353 | good bad | |
IR | infarcted region | 1 | 312 | good bad | |
IR | (CB)-immunoreactive | 1 | 311 | good bad | |
IR | (PV)-immunoreactive | 1 | 265 | good bad | |
IR | VRL-1-immunoreactive | 1 | 235 | good bad | |
IR | L-DOPA-immunoreactive | 1 | 215 | good bad | |
IR | Immunohistochemical analyses revealed that c-Met-immunoreactivity | 1 | 129 | good bad | |
IR | investigate the release of immunoreactive | 1 | 123 | good bad | |
IR | innervated by CARTp-immunoreactive | 1 | 109 | good bad | |
IR | intra-rectal | 1 | 95 | good bad | |
IR | TRH-immunoreactive | 1 | 90 | good bad | |
IR | GAT-1-immunoreactivity | 1 | 88 | good bad | |
IR | Is detected by infrared | 1 | 86 | good bad | |
IR | impulse response | 1 | 76 | good bad | |
IR | identified by immunoreactivity | 1 | 73 | good bad | |
IR | (GnRH)-immunoreactive | 1 | 71 | good bad | |
IR | in calcitonin gene-related peptide (CGRP)-immunoreactive | 1 | 71 | good bad | |
IR | (ACTH)-immunoreactive | 1 | 70 | good bad | |
IR | X-irradiation | 1 | 68 | good bad | |
IR | II insulin-requiring | 1 | 68 | good bad | |
IR | irrigation | 1 | 67 | good bad | |
IR | in response to gamma-irradiation | 1 | 67 | good bad | |
IR | immunocytochemistry NGF-immunoreactive | 1 | 66 | good bad | |
IR | Inflammatory resorption | 1 | 65 | good bad | |
IR | SN-immunoreactive | 1 | 65 | good bad | |
IR | Ir-coated catheter | 1 | 64 | good bad | |
IR | CR-immunoreactivity | 1 | 60 | good bad | |
IR | irritant reaction | 1 | 42 | good bad | |
IR | infra red | 1 | 23 | good bad | |
IR | IFABP-immunoreactive | 1 | 20 | good bad | |
IR | interstitial radiotherapy | 1 | 20 | good bad | |
IR | mutant K | 1 | 18 | good bad | |
IR | Index of Recession | 1 | 16 | good bad | |
IR | Na+/K+-ATPase-immunoreactive | 1 | 15 | good bad | |
IR | infrared spectrum | 1 | 15 | good bad | |
IR | infrared analysis | 1 | 15 | good bad | |
IR | Bcl-2-immunoreactivity | 1 | 15 | good bad | |
IR | increased the pituitary content of Beta-endorphin | 1 | 14 | good bad | |
IR | increase in immunoreactive | 1 | 14 | good bad | |
IR | S100-immunoreactive | 1 | 14 | good bad | |
IR | cathepsin-immunoreactive | 1 | 13 | good bad | |
IR | Anti-mGluR2/3-immunoreactive | 1 | 13 | good bad | |
IR | impregnation ratio | 1 | 13 | good bad | |
IR | interposition | 1 | 13 | good bad | |
IR | cell surface receptor | 1 | 12 | good bad | |
IR | beta-endorphin-immunoreactive | 1 | 12 | good bad | |
IR | II (A II) immunoreactivity | 1 | 12 | good bad | |
IR | insulin resistance HOMA | 1 | 12 | good bad | |
IR | investigate the presence of immunoreactive | 1 | 12 | good bad | |
IR | VR1-immunoreactive | 1 | 12 | good bad | |
IR | in the HOMA-insulin resistant | 1 | 12 | good bad | |
IR | CGRP-immunoreactivity | 1 | 12 | good bad | |
IR | (TH)-only-immunoreactive | 1 | 11 | good bad | |
IR | 4-immunoreactivity | 1 | 11 | good bad | |
IR | inflammatory response | 1 | 11 | good bad | |
IR | internal repeats | 1 | 11 | good bad | |
IR | ischaemia reperfusion | 1 | 11 | good bad | |
IR | irregular regeneration of hepatocytes | 1 | 11 | good bad | |
IR | inhibitory rates | 1 | 11 | good bad | |
IR | in the appearance of ChAT-immunoreactivity | 1 | 11 | good bad | |
IR | inventory ratio | 1 | 11 | good bad | |
IR | irrigated rice | 1 | 10 | good bad | |
IR | (TH)-only'-immunoreactive | 1 | 10 | good bad | |
IR | (bFGF)-immunoreactivity | 1 | 10 | good bad | |
IR | internal repeat | 1 | 10 | good bad | |
IR | in rat K | 1 | 10 | good bad | |
IR | intestinal vascular endothelium after ischemia/reperfusion | 1 | 9 | good bad | |
IR | C-ACTH-immunoreactive | 1 | 9 | good bad | |
IR | investigates immunoreactive | 1 | 9 | good bad | |
IR | investigated the maturation of TK-immunoreactive | 1 | 9 | good bad | |
IR | II immunoreactivity | 1 | 9 | good bad | |
IR | IGF-I receptor (IGF-IR) and insulin receptor | 1 | 9 | good bad | |
IR | Immuno-reactive | 1 | 9 | good bad | |
IR | min-ischemia-reperfusion | 1 | 9 | good bad | |
IR | regulated by immune response | 1 | 9 | good bad | |
IR | Immunohistochemical analysis revealed PACAP-immunoreactivity | 1 | 9 | good bad | |
IR | [NGFr(p75)]-immunoreactivity | 1 | 9 | good bad | |
IR | intrarenal | 1 | 8 | good bad | |
IR | (GAD)-immunoreactivity | 1 | 8 | good bad | |
IR | inverted-repeat | 1 | 8 | good bad | |
IR | ischemic region | 1 | 8 | good bad | |
IR | inwardly rectifying K+ current | 1 | 8 | good bad | |
IR | (GR)-immunoreactivity | 1 | 7 | good bad | |
IR | Immunocytochemistry showed intensely stained NOS-immunoreactive | 1 | 7 | good bad | |
IR | imidazol(in)e | 1 | 7 | good bad | |
IR | Individual GFAP immunoreactive | 1 | 7 | good bad | |
IR | (NPF)-immunoreactivity | 1 | 7 | good bad | |
IR | intestinal ischemia-reperfusion | 1 | 7 | good bad | |
IR | MCH-immunoreactive | 1 | 7 | good bad | |
IR | trk-immunoreactivity | 1 | 7 | good bad | |
IR | (SN)-immunoreactivity | 1 | 7 | good bad | |
IR | intermediate region | 1 | 7 | good bad | |
IR | infrared marker | 1 | 7 | good bad | |
IR | intermediate-range | 1 | 6 | good bad | |
IR | synaptophysin-immunoreactivity | 1 | 6 | good bad | |
IR | intermediate risk | 1 | 6 | good bad | |
IR | CGA-immunoreactive | 1 | 6 | good bad | |
IR | intermediate | 1 | 6 | good bad | |
IR | insulin levels and HOMA | 1 | 6 | good bad | |
IR | inward rectification | 1 | 6 | good bad | |
IR | isotope ratio | 1 | 6 | good bad | |
IR | infection rate | 1 | 6 | good bad | |
IR | CB-immunoreactive | 1 | 6 | good bad | |
IR | CCK-immunoreactive | 1 | 6 | good bad | |
IR | NK-1r-immunoreactive | 1 | 6 | good bad | |
IR | CRH-immunoreactivity | 1 | 6 | good bad | |
IR | intestinal resection | 1 | 6 | good bad | |
IR | intensity | 1 | 6 | good bad | |
IR | initiator region | 1 | 6 | good bad | |
IR | inactivation response | 1 | 6 | good bad | |
IR | glycine-immunoreactive | 1 | 6 | good bad | |
IR | in groups II | 1 | 6 | good bad | |
IR | infra-red spectroscopy | 1 | 6 | good bad | |
IR | implications of p63 immunoreactivity | 1 | 6 | good bad | |
IR | infectious rhinotracheitis | 1 | 6 | good bad | |
IR | Ischemic preconditioning protects against ischemia-reperfusion | 1 | 5 | good bad | |
IR | (PNMT)-immunoreactive | 1 | 5 | good bad | |
IR | initiation region | 1 | 5 | good bad | |
IR | nNOS-immunoreactive | 1 | 5 | good bad | |
IR | intestinal peptide)-immunoreactive | 1 | 5 | good bad | |
IR | investigated using mid-infrared spectroscopy | 1 | 5 | good bad | |
IR | inactive trypsin-activatable renin | 1 | 5 | good bad | |
IR | in met-enkephalin-immunoreactivity | 1 | 5 | good bad | |
IR | GAD-immunoreactivity | 1 | 5 | good bad | |
IR | increased radio-resistence at higher doses | 1 | 5 | good bad | |
IR | inosine | 1 | 5 | good bad | |
IR | Y1-R-immunoreactive | 1 | 4 | good bad | |
IR | identified by synapsin-1 immunoreactivity | 1 | 4 | good bad | |
IR | idiopathic radioculopolyneuropathies | 1 | 4 | good bad | |
IR | infrared reflection | 1 | 4 | good bad | |
IR | c-Met-immunoreactivity | 1 | 4 | good bad | |
IR | vasopressin-immunoreactive | 1 | 4 | good bad | |
IR | implant withdrawal | 1 | 4 | good bad | |
IR | (NT)-immunoreactive | 1 | 4 | good bad | |
IR | items that varied on category | 1 | 4 | good bad | |
IR | (S1)-immunoreactivity | 1 | 4 | good bad | |
IR | incidence ratio | 1 | 4 | good bad | |
IR | ED1-immunoreactivity | 1 | 4 | good bad | |
IR | (NF)-immunoreactive | 1 | 4 | good bad | |
IR | SMI32-immunoreactive | 1 | 4 | good bad | |
IR | (PR)-immunoreactive | 1 | 4 | good bad | |
IR | ET-immunoreactivity | 1 | 4 | good bad | |
IR | leu-enkephalin-immunoreactive | 1 | 4 | good bad | |
IR | Initial drug resistance | 1 | 4 | good bad | |
IR | increase in plasma immunoreactive | 1 | 4 | good bad | |
IR | NC-immunoreactive | 1 | 4 | good bad | |
IR | ischaemia and 90 min reperfusion | 1 | 3 | good bad | |
IR | immunoreactive renin | 1 | 3 | good bad | |
IR | increase in MOR immunoreactivity | 1 | 3 | good bad | |
IR | ischaemia reperfusion untreated | 1 | 3 | good bad | |
IR | inwardly rectifying K(+) channels (K | 1 | 3 | good bad | |
IR | incomplete-repair | 1 | 3 | good bad | |
IR | VMAT2-immunoreactivity | 1 | 3 | good bad | |
IR | intense NCS-1-immunoreactive | 1 | 3 | good bad | |
IR | insulin resistance index | 1 | 3 | good bad | |
IR | galanin-immunoreactive | 1 | 3 | good bad | |
IR | in response to ionizing radiation | 1 | 3 | good bad | |
IR | in the distribution of PV-immunoreactive | 1 | 3 | good bad | |
IR | SK3-immunoreactivity | 1 | 3 | good bad | |
IR | sGnRH-immunoreactive | 1 | 3 | good bad | |
IR | intestinal pathology in intestinal ischemia-reperfusion | 1 | 3 | good bad | |
IR | inspiratory resistor | 1 | 3 | good bad | |
IR | Inhibition rates | 1 | 3 | good bad | |
IR | increase in PSA-NCAM-immunoreactive | 1 | 2 | good bad | |
IR | (NKA)-immunoreactivity | 1 | 2 | good bad | |
IR | isometric relaxation | 1 | 2 | good bad | |
IR | mGnRH-immunoreactive | 1 | 2 | good bad | |
IR | in EAAT1-immunoreactivity | 1 | 2 | good bad | |
IR | including ROM and isokinetic internal rotation | 1 | 2 | good bad | |
IR | isovolumic relaxation | 1 | 2 | good bad | |
IR | increases Beta-endorphin | 1 | 2 | good bad | |
IR | inhibitory response | 1 | 2 | good bad | |
IR | Inwardly rectifying K(+) currents (K | 1 | 2 | good bad | |
IR | iron reserves | 1 | 2 | good bad | |
IR | infrared absorption | 1 | 2 | good bad | |
IR | inertial range | 1 | 2 | good bad | |
IR | II (ANG II)-like immunoreactivities | 1 | 2 | good bad | |
IR | indicated that the SL-immunoreactive | 1 | 2 | good bad | |
IR | I receptor (IGF-IR) on ionizing radiation | 1 | 2 | good bad | |
IR | initiation | 1 | 2 | good bad | |
IR | significantly associated with the | 1 | 1 | good bad | |
IR | OA-immunoreactive | 1 | 1 | good bad | |
IR | (NK1R)-immunoreactive | 1 | 1 | good bad | |
IR | inversion-time (TI) inversion-recovery | 1 | 1 | good bad | |
IR | ET-1-immunoreactive | 1 | 1 | good bad | |
IR | (DA)-immunoreactive | 1 | 1 | good bad | |
IR | in the infrared | 1 | 1 | good bad | |
IR | insulin resistant | 1 | 1 | good bad | |
IR | inwardly rectifying K(+) currents (I | 1 | 1 | good bad | |
IR | TrkA-immunoreactive | 1 | 1 | good bad | |
IR | 5-HT-immunoreactive | 1 | 1 | good bad | |
IR | (5-HT)-immunoreactivity | 1 | 0 | good bad | |
IR | interstitial radiation | 1 | 0 | good bad | |
IR | I(h) and I(K | 1 | 0 | good bad | |
IR | (CGRP)-immunoreactivity | 1 | 0 | good bad | |
IR | innervation of histamine-immunoreactive | 1 | 0 | good bad | |
IR | TRH-immunoreactivity | 1 | 0 | good bad | |
IR | (GAL)-immunoreactive | 1 | 0 | good bad | |
IR | inwardly rectifying potassium current | 1 | 0 | good bad | |
IR | immunoreaction product | 1 | 0 | good bad | |
IR | identical ischemia-reperfusion | 1 | 0 | good bad | |
IR | alpha-immunoreactivity | 1 | 0 | good bad | |
IR | intestinal polypeptide (VIP) immunoreactive | 1 | 0 | good bad | |
IR | immobility responses | 1 | 0 | good bad | |
IR | increased immunoreactivity | 1 | -1 | good bad | |
IR | immune response genes | 1 | -1 | good bad | |
IR | interstitial ratio | 1 | -1 | good bad | |
IR | immediate hypersensitivity responses | 1 | -1 | good bad | |
IR | insulin stimulation of NIH-3T3 | 1 | -1 | good bad | |
IR | infrasonic recorder | 1 | -1 | good bad | |
IR | identification in TECs/TNCs of immunoreactive | 1 | -2 | good bad | |
IR | initial virological response | 1 | -2 | good bad | |
IR | (VT)-immunoreactive | 1 | -2 | good bad | |
IR | D28k-immunoreactivity | 1 | -2 | good bad |
|
Text2Knowledge ... Yong Huang
2002
|